China’s CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial | FiercePharma

Among a long list of biopharma companies developing vaccines against the novel coronavirus, China’s CanSino Biologics and Massachusetts-based Moderna Therapeutics are so far the front-runners. After Moderna dosed its first subject this week, CanSino said it’s been cleared to start its trials.

Source: China’s CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial | FiercePharma

Among a long list of biopharma companies developing vaccines against the novel coronavirus, China’s CanSino Biologics and Massachusetts-based Moderna Therapeutics are so far the front-runners.

CanSino Bio and its collaborators at the Academy of Military Medical Sciences’ Institute of Biotechnology secured a quick Chinese regulatory go-ahead to start human testing of their recombinant coronavirus vaccine, the company said in a disclosure (PDF) to the Hong Kong Stock Exchange on Wednesday.

“Thanks to our collaborators and our diligent team, who worked almost around the clock since late January to develop this vaccine candidate with sound scientific data to support IND filing,” CanSino Chairman and CEO Xuefeng Yu said in a statement.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.